Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Cogstate Ltd ( (AU:CGS) ).
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program, with a total of 210,288 ordinary fully paid securities bought back on the previous day, adding to the cumulative total of 5,571,816 securities repurchased. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value, reflecting a proactive approach in managing its financial resources.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in the development and commercialization of cognitive tests and assessments. The company focuses on providing solutions for clinical trials, academic research, and healthcare markets, aiming to enhance the measurement of cognitive function.
Average Trading Volume: 113,628
Technical Sentiment Signal: Buy
Current Market Cap: A$235.5M
See more data about CGS stock on TipRanks’ Stock Analysis page.